This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Melaleuca Incorporated. Active years: 2020.
Company Filing History:
Years Active: 2020
Title: Bruno Fink: Innovator in Antiplatelet Activity Measurement
Introduction
Bruno Fink is a notable inventor based in Elzach, Germany. He has made significant contributions to the field of medical technology, particularly in the assessment of platelet activity. His innovative work has implications for understanding and treating various cardiovascular conditions.
Latest Patents
Bruno Fink holds a patent for a method titled "Measuring Antiplatelet Activity." This patent outlines methods and materials for assessing platelet activity and the ability of substances to inhibit or activate this activity. The patent describes applying abnormal flow conditions, such as oscillatory shear stress, to stimulate platelets in a sample. It also details how to assess platelet activity by measuring superoxide radicals or the rate and level of platelet aggregation within the sample. This patent represents a significant advancement in the field of hematology.
Career Highlights
Throughout his career, Bruno Fink has worked with various companies, including Melaleuca Incorporated and Noxygen Science Transfer & Diagnostics GmbH. His experience in these organizations has allowed him to develop and refine his innovative ideas in the medical technology sector.
Collaborations
Bruno has collaborated with notable individuals in his field, including Alexander B. Rabovsky and Arthur Fink. These collaborations have contributed to the advancement of his research and the successful development of his patent.
Conclusion
Bruno Fink's contributions to the measurement of antiplatelet activity highlight his innovative spirit and dedication to improving medical technology. His patent and career achievements reflect his commitment to advancing healthcare solutions.